Citadel Advisors’s iShares Global Healthcare ETF IXJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-200
Closed -$19.6K 14942
2024
Q3
$19.6K Buy
200
+100
+100% +$9.7K ﹤0.01% 12789
2024
Q2
$9.28K Hold
100
﹤0.01% 13145
2024
Q1
$9.31K Sell
100
-400
-80% -$36.2K ﹤0.01% 13510
2023
Q4
$43.4K Buy
+500
New +$41.4K ﹤0.01% 11933
2023
Q3
Sell
-1,200
Closed -$102K 14696
2023
Q2
$102K Sell
1,200
-1,200
-50% -$102K ﹤0.01% 10905
2023
Q1
$200K Sell
2,400
-3,100
-56% -$257K ﹤0.01% 10188
2022
Q4
$467K Buy
5,500
+2,000
+57% +$165K ﹤0.01% 8383
2022
Q3
$264K Buy
+3,500
New +$283K ﹤0.01% 9847

Other funds holding IXJ

Citadel Advisors's IXJ Position: Q1 2026 in Review

Citadel Advisors increased its iShares Global Healthcare ETF (IXJ) stake by 15% in Q1 2026, buying an estimated $733K and bringing the position to 56,307 shares worth $5.27M. The position accounts for ﹤0.01% of the portfolio, ranked #4259.

Citadel Advisors first reported a position in IXJ in Q1 2014 and has held it in 33 quarters since. The position peaked at $15.5M in Q3 2015. 285 funds tracked by Wall St. Rank hold IXJ as of Q1 2026.

  • Citadel Advisors held 56,307 shares of iShares Global Healthcare ETF worth $5.27M as of Q1 2026.
  • Citadel Advisors bought 7,481 iShares Global Healthcare ETF shares in Q1 2026, an estimated $733K.
  • iShares Global Healthcare ETF made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #4259 holding.
  • Citadel Advisors first reported a position in iShares Global Healthcare ETF in Q1 2014 and has held it in 33 quarters since.
  • Citadel Advisors's iShares Global Healthcare ETF position peaked at $15.5M in Q3 2015.
  • 285 funds tracked by Wall St. Rank held iShares Global Healthcare ETF as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.